- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04274088
The Clinical Importance of Angle Alpha by Multifocal Intraocular Lenses.
February 19, 2020 updated by: Kata Mihaltz, Hospital Hietzing
The Impact of Visual Axis Position on the Optical Quality After Implantation of Multifocal Intraocular Lenses With Different Asphericity Values
Purpose: to evaluate the effect of visual axis positioning on the optical performance of the Tecnis MIOL and the Diff-aA MIOL.
Study Overview
Detailed Description
In this prospective, randomized comparative study 70 eyes of 35 subjects with senile cataract were implanted with the spherical aberration correcting diffractive, bifocal Tecnis ZLB00 IOL, and 60 eyes of 30 age matched subjects with the spherical aberration neutral, diffractive, bifocal Diffractiva IOL.
Observation Procedure was performed 1, 3, 6 months postoperatively.
Main Outcome Measures included uncorrected and corrected distance and near visual acuity, manifest refraction, ocular aberrations and visual quality metrics with 2mm and 4mm pupil, and the position of visual axis.
Study Type
Observational
Enrollment (Actual)
65
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients of the clinic
Description
Inclusion Criteria:
- corneal astigmatism less than 1 diopter
Exclusion Criteria:
- ocular pathology others than cataract
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Tecnis;
Patients who received the Tecnis multifocal IOL.
|
Phacoemulsification surgery
|
Diffractiva
Patients who received the Diffractiva multifocal IOL.
|
Phacoemulsification surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Acuity
Time Frame: 6 Month
|
Schnellen VA
|
6 Month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2014
Primary Completion (Actual)
October 1, 2016
Study Completion (Actual)
October 1, 2018
Study Registration Dates
First Submitted
February 14, 2020
First Submitted That Met QC Criteria
February 17, 2020
First Posted (Actual)
February 18, 2020
Study Record Updates
Last Update Posted (Actual)
February 21, 2020
Last Update Submitted That Met QC Criteria
February 19, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HHietzing3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on IOL, Cataract
-
Cutting Edge SASRecruitingCataract | Surgery | IOLFrance
-
Wenzhou Medical UniversityEnrolling by invitation
-
Kazakh Eye Research InstituteRecruitingAstigmatism | IOL | Cataract CongenitalKazakhstan
-
Seoul National University HospitalUnknownAstigmatism | IolKorea, Republic of
-
Bucci Laser Vision InstituteCompletedCataract | Patient Satisfaction | IOLUnited States
-
TrueVision Systems, IncCompletedSubjects Undergoing Cataract Surgery and Insertion of IOLUnited States
-
Enrique Ordiñaga-Monreal, OD, MScUnknownAstigmatism | Visual Acuity | IOL | Cataract AfterSpain
-
Iladevi Cataract and IOL Research CenterCompletedCongenital Cataract Surgery | IOL Implantation | Change in Corneal Endothelial Cell Morphology
-
Iladevi Cataract and IOL Research CenterCompletedPosterior Capsule Opacification After Phacoemulsification and IOL ImplantationIndia
Clinical Trials on Cataract surgery
-
Iladevi Cataract and IOL Research CenterCompletedCataract Surgery | Shallow Anterior Chamber | PhacoemulsificationIndia
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
University of OklahomaCompletedPrimary Open Angle Glaucoma | Cataract | Pigmentary GlaucomaUnited States
-
Glaukos CorporationCompletedOpen-Angle GlaucomaUnited States
-
Ziemer Ophthalmic Systems AGRecruiting
-
Technolas Perfect Vision GmbHCompleted
-
Sun Yat-sen UniversityCompleted
-
Guy's and St Thomas' NHS Foundation TrustCompletedCataract | Surgery
-
University Hospital, BordeauxCompleted